Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association
Circulation, 2011•Am Heart Assoc
Background—Cardiovascular disease (CVD) is the leading cause of death in the United
States and is responsible for 17% of national health expenditures. As the population ages,
these costs are expected to increase substantially. Methods and Results—To prepare for
future cardiovascular care needs, the American Heart Association developed methodology
to project future costs of care for hypertension, coronary heart disease, heart failure, stroke,
and all other CVD from 2010 to 2030. This methodology avoided double counting of costs …
States and is responsible for 17% of national health expenditures. As the population ages,
these costs are expected to increase substantially. Methods and Results—To prepare for
future cardiovascular care needs, the American Heart Association developed methodology
to project future costs of care for hypertension, coronary heart disease, heart failure, stroke,
and all other CVD from 2010 to 2030. This methodology avoided double counting of costs …
Background
Cardiovascular disease (CVD) is the leading cause of death in the United States and is responsible for 17% of national health expenditures. As the population ages, these costs are expected to increase substantially.
Methods and Results
To prepare for future cardiovascular care needs, the American Heart Association developed methodology to project future costs of care for hypertension, coronary heart disease, heart failure, stroke, and all other CVD from 2010 to 2030. This methodology avoided double counting of costs for patients with multiple cardiovascular conditions. By 2030, 40.5% of the US population is projected to have some form of CVD. Between 2010 and 2030, real (2008 )totaldirectmedicalcostsofCVDareprojectedtotriple,from 273 billion to 818billion.Realindirectcosts(duetolostproductivity)forallCVDareestimatedtoincreasefrom 172 billion in 2010 to 276billionin2030,anincreaseof61%.
Conclusions
ThesefindingsindicateCVDprevalenceandcostsareprojectedtoincreasesubstantially.EffectivepreventionstrategiesareneededifwearetolimitthegrowingburdenofCVD.
Am Heart Assoc